Research & Education

Researchers find two new methods to determine ALK status

Tests continue trend in personalize medicine for lung cancer patients

DENVER – The implementation of personalized health care in cancer relies on the identification and characterization of cancer biomarkers and the av

Researchers use immunocytochemistry to determine ALK status

Tests continue trend in personalize medicine for lung cancer patients

DENVER – Personalized medicine in lung cancer relies on the identification and characterization of cancer biomarkers and the availability of accura

PET-CT improves care of limited-stage small-cell lung cancer patients

Researchers find improved overall survival for LS-SCLC patients

DENVER – Each year, 13 percent of all newly diagnosed lung cancer patients are diagnosed with small-cell lung cancer (SCLC).

Study supports continued research on specific treatment for women with lung cancer who are never-smokers

This lung cancer associated with EGFR mutation and ER expression

DENVER – The incidence of lung cancer in women affects an estimated 516,000 women worldwide, of which 100,000 are in the United States and 70,000 i

Immunohistochemistry effectively detects ALK rearrangement

Could be reliable and cost-effective diagnostic approach in lung cancer

DENVER – ALK rearrangement has been demonstrated to be a potent oncogenic driver and a promising therapeutic target in non-small cell lung cancer (

Digital chest tomosynthesis possible lung cancer screening tool

Detection rate comparable to CT screening at a lower cost

DENVER – Most lung cancers are detected when patients become symptomatic and have latestage disease.

Pages